Kiyoko K et al. indicated that CD24 induces epithelial-mesenchymal transition via both the PI3K/Akt and ERK pathways, and CD24+ cells are related to cisplatin resistance in ovarian cancer cells [41]. The gene discussed is AKT1; the disease is ovarian cancer.